XTNT logo

Xtant Medical Holdings (XTNT) Company Overview

Profile

Full Name:

Xtant Medical Holdings, Inc.

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

July 1, 2010

Indexes:

Not included

Website:

http://www.xtantmedical.com

Description:

Xtant Medical Holdings (XTNT) is a medical technology company that specializes in developing and providing innovative solutions for spinal surgery and orthopedic procedures. They focus on advanced implants and biologics to improve patient outcomes and support healthcare professionals in delivering effective treatments.

Key Details

Price

$0.54

Market Cap

$75.66 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$91.30 M(+57.50% YoY)

Annual EPS

$0.01(+111.11% YoY)

PE Ratio

-

Annual ROE

1.54%

Annual Debt To Equity

0.42

Beta

1.54

Events Calendar

Earnings

Next earnings date:

Apr 1, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Apr 1, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Feb 14, 2018

Analyst ratings

Recent major analysts updates

May 16, 24 BTIG
Buy
Dec 5, 23 BTIG
Buy
Jul 11, 23 Craig-Hallum
Buy
Apr 26, 23 Craig-Hallum
Buy
May 17, 19 Maxim Group
Hold
Dec 8, 16 Maxim Group
Buy
Nov 30, 16 Aegis Capital
Buy

Screeners with XTNT included

Growing Shares Outstanding
Stocks cheaper than 1 dollar
US stocks
Stocks with high beta
Most recommended stocks
Best performing stocks last 3 months
Biggest stock gainers today
Stocks below analysts price target
Healthcare sector
All stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.54
XTNT price is $0.54

Price All-time High

$1074.00
XTNT price is currently -99.95% below its historical high of $1074.00

Price Analysts Target

$2.25
XTNT price is currently -75.81% lower than the consensus analysts' forecast

Price Most Recent Change

+29.6%
XTNT price was up +29.6% on Mar 6, 2025

Price YTD Change

+8.86%
XTNT price is up +8.86% since January 1st

Price 3-Year Change

-35.2%
XTNT price is down -35.2% over the past 3 years

Market cap

Market Cap

$75.66 M
XTNT market capitalization is $75.66 million

Market Cap 3-Year Change

+3.16%
XTNT market capitalization is up +3.16% over the past 3 years

Market Cap All-time High

$375.44 M
XTNT market capitalization is currently -79.85% below its historical high of $375.44 million

Market Cap Sector Rank

42.22%
XTNT market capitalization is higher than 42.22% of companies in Healthcare sector

Technical

Beta

1.54
XTNT beta is 1.54

200-day SMA

$0.59
XTNT price is currently -7.45% below its 200-day simple moving average

14-day RSI

44.53
XTNT 14-day relative strength index is 44.53

30-day Relative Volume

0.15
XTNT 30-day relative volume is 0.15

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$91.30 M
XTNT annual revenue is $91.30 million

Annual Revenue Analysts Estimate

$117.50 M
XTNT annual revenue is currently -22.30% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+57.5%
XTNT annual revenue is up +57.5% year-on-year

Annual Revenue Sector Rank

56.53%
XTNT annual revenue is higher than 56.53% of companies in Healthcare sector

Profit

Annual Gross Profit

$55.47 M
XTNT annual gross profit is $55.47 million

Annual Gross Margin

60.75%
XTNT annual gross profit margin is 60.75%

Annual Operating Profit

-$10.16 M
XTNT annual operating income is -$10.16 million

Annual Operating Margin

-11.13%
XTNT annual operating profit margin is -11.13%

Annual Net Income

$660.00 K
XTNT annual net profit is $660.00 thousand

Annual Net Margin

0.72%
XTNT annual net profit margin is 0.72%

EPS

Annual EPS

$0.01
XTNT annual earnings per share is $0.01

Annual EPS Analysts Estimate

-$0.12
XTNT annual earnings per share is currently -108.33% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+111.11%
XTNT annual earnings per share is up +111.11% year-on-year

Annual EPS Sector Rank

82.38%
XTNT annual earnings per share is higher than 82.38% of companies in Healthcare sector

ROA & ROE

Annual ROA

0.86%
XTNT annual return on assets is 0.86%

Annual ROE

1.54%
XTNT annual return on equity is 1.54%

EBIT & EBITDA

Annual EBIT

$1.90 M
XTNT annual earnings before interest & taxes is $1.90 million

Annual EBITDA

$5.08 M
XTNT annual EBITDA is $5.08 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
XTNT price to earnings ratio value is unknown

PE Ratio Sector Rank

-
XTNT price to earnings ratio is unknown

PB Ratio

PB Ratio

1.65
XTNT price to book ratio is 1.65

PB Ratio Sector Rank

54.62%
XTNT price to book ratio is higher than 54.62% of companies in Healthcare sector

PS Ratio

PS Ratio

0.66
XTNT price to sales ratio is 0.66

PS Ratio Sector Rank

18.18%
XTNT price to sales ratio is higher than 18.18% of companies in Healthcare sector

Enterprise value

Enterprise Value

$105.02 M
XTNT enterprise value is $105.02 million

Enterprise Value Sector Rank

48.45%
XTNT enterprise value is higher than 48.45% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-11.79
XTNT EV/EBITDA is -11.79

EV/EBITDA Sector Rank

11.14%
XTNT EV/EBITDA is higher than 11.14% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

2.82
XTNT annual current ratio is 2.82

Annual Quick Ratio

1.22
XTNT annual quick ratio is 1.22

Leverage

Annual Debt To Equity

0.42
XTNT annual debt to equity ratio is 0.42

Annual Interest Coverage Ratio

0.65
XTNT annual interest coverage ratio is 0.65

Risk & Stability

Piotroski F-Score

2
XTNT piotroski f-score is 2

Altman Z-Score

-0.98
XTNT altman z-score is -0.98

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$92.61 M
XTNT annual total assets is $92.61 million

Annual Non Current Assets

$27.74 M
XTNT annual long term assets is $27.74 million

Annual Current Assets

$64.87 M
XTNT annual total current assets is $64.87 million

Annual Cash & Cash Equivalents

$5.71 M
XTNT annual cash & cash equivalents is $5.71 million

Equity

Annual Book Value

$51.35 M
XTNT annual book value is $51.35 million

Annual Working Capital

$41.88 M
XTNT annual working capital is $41.88 million

Liabilities

Annual Total Liabilities

$41.26 M
XTNT annual total liabilities is $41.26 million

Annual Total Long Term Liabilities

$18.27 M
XTNT annual total long term liabilities is $18.27 million

Annual Current Liabilities

$22.99 M
XTNT annual total current liabilities is $22.99 million

Annual Accounts Payable

$7.05 M
XTNT annual accounts payable is $7.05 million

Debt

Annual Total Debt

$23.56 M
XTNT annual total debt is $23.56 million

Annual Total Debt 1-Year Change

+38%
XTNT annual total debt is up +38% year-on-year

Annual Long Term Debt

$18.04 M
XTNT annual long term debt is $18.04 million

Annual Short Term Debt

$5.52 M
XTNT annual short term debt is $5.52 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$101.46 M
XTNT annual total expenses is $101.46 million

Annual Operating Expenses

$65.63 M
XTNT annual total operating expenses is $65.63 million

Annual Cost Of Goods Sold

$35.84 M
XTNT annual cost of goods sold is $35.84 million

Annual SGA

$64.29 M
XTNT annual SGA is $64.29 million

Annual D&A

$3.17 M
XTNT annual depreciation & amortization is $3.17 million

Annual Interest Expense

$2.94 M
XTNT annual interest expense is $2.94 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$9.52 M
XTNT annual cash flow from operations is -$9.52 million

Annual CFO 1-Year Change

-78.15%
XTNT annual cash flow from operations is down -78.15% year-on-year

Annual CFI

-$24.78 M
XTNT annual cash flow from investing activities is -$24.78 million

Annual CFI 1-Year Change

-1489.74%
XTNT annual cash flow from investing activities is down -1489.74% year-on-year

Annual CFF

$19.69 M
XTNT annual cash flow from financing activities is $19.69 million

Annual CFF 1-Year Change

+118.3%
XTNT annual cash flow from financing activities is up +118.3% year-on-year

Free CashFlow

Annual FCF

-$10.97 M
XTNT annual free cash flow is -$10.97 million

Annual FCF 1-Year Change

-54.41%
XTNT annual free cash flow is down -54.41% year-on-year

CAPEX

Annual CAPEX

$1.46 M
XTNT annual capital expenditures is $1.46 million

Annual CAPEX 1-Year Change

-17.46%
XTNT annual capital expenditures is down -17.46% year-on-year

Institutional Ownership

Similar stocks

NSPR logo
InspireMD (NSPR)
Basel Medical Group Ltd (BMGL)
YI logo
111 (YI)
GUTS logo
Fractyl Health (GUTS)
VERU logo
Veru (VERU)
ASMB logo
Assembly Biosciences (ASMB)
THTX logo
Theratechnologies (THTX)
IFRX logo
InflaRx NV (IFRX)
GNTA logo
Genenta Science SpA (GNTA)

FAQ

  • What is the ticker symbol for Xtant Medical Holdings?
  • Does Xtant Medical Holdings pay dividends?
  • What sector is Xtant Medical Holdings in?
  • What industry is Xtant Medical Holdings in?
  • What country is Xtant Medical Holdings based in?
  • When did Xtant Medical Holdings go public?
  • Is Xtant Medical Holdings in the S&P 500?
  • Is Xtant Medical Holdings in the NASDAQ 100?
  • Is Xtant Medical Holdings in the Dow Jones?
  • When was Xtant Medical Holdings's last earnings report?
  • When does Xtant Medical Holdings report earnings?
  • Should I buy Xtant Medical Holdings stock now?

What is the ticker symbol for Xtant Medical Holdings?

The ticker symbol for Xtant Medical Holdings is NYSE American:XTNT

Does Xtant Medical Holdings pay dividends?

No, Xtant Medical Holdings does not pay dividends

What sector is Xtant Medical Holdings in?

Xtant Medical Holdings is in the Healthcare sector

What industry is Xtant Medical Holdings in?

Xtant Medical Holdings is in the Medical Devices industry

What country is Xtant Medical Holdings based in?

Xtant Medical Holdings is headquartered in United States

When did Xtant Medical Holdings go public?

Xtant Medical Holdings's initial public offering (IPO) was on July 1, 2010

Is Xtant Medical Holdings in the S&P 500?

No, Xtant Medical Holdings is not included in the S&P 500 index

Is Xtant Medical Holdings in the NASDAQ 100?

No, Xtant Medical Holdings is not included in the NASDAQ 100 index

Is Xtant Medical Holdings in the Dow Jones?

No, Xtant Medical Holdings is not included in the Dow Jones index

When was Xtant Medical Holdings's last earnings report?

Xtant Medical Holdings's most recent earnings report was on Nov 12, 2024

When does Xtant Medical Holdings report earnings?

The next expected earnings date for Xtant Medical Holdings is Apr 1, 2025

Should I buy Xtant Medical Holdings stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions